Workshop Held On-Site in Cote d'Ivoire, Africa

The National Cancer Center announced on the 5th that, as part of the Korea International Cooperation Agency (KOICA) Official Development Assistance (ODA) project, it jointly held a two-day workshop with the Ministry of Health of Cote d'Ivoire and the National Cancer Control Program (PNLCa) in Abidjan, Cote d'Ivoire, from the 27th to the 28th of last month to establish an early detection system for prostate cancer in Cote d'Ivoire.


The National Cancer Center held a two-day joint workshop in Abidjan, Cote d'Ivoire, from the 27th to the 28th of last month with the Ministry of Health of Cote d'Ivoire and the National Cancer Control Program (PNLCa) to establish an early detection system for prostate cancer as part of a Korea International Cooperation Agency (KOICA) Official Development Assistance (ODA) project. National Cancer Center

The National Cancer Center held a two-day joint workshop in Abidjan, Cote d'Ivoire, from the 27th to the 28th of last month with the Ministry of Health of Cote d'Ivoire and the National Cancer Control Program (PNLCa) to establish an early detection system for prostate cancer as part of a Korea International Cooperation Agency (KOICA) Official Development Assistance (ODA) project. National Cancer Center

View original image

In Cote d'Ivoire, prostate cancer is the cancer with both the highest incidence and mortality rates. Approximately 75% of cases are diagnosed only after they have already progressed to the distant metastasis stage, and the survival rate remains below 50%. This stands in sharp contrast to the situation in Korea and other advanced Western countries, where the 5-year survival rate for prostate cancer is close to 100%. Against this backdrop, the workshop was organized with the goal of formulating a mid- to long-term roadmap linked to national health policy, in order to raise public awareness, strengthen the capabilities of medical personnel through training, and thereby increase the early detection rate of prostate cancer in Cote d'Ivoire.


About 80 key stakeholders took part in the workshop, including experts and working-level staff from the National Cancer Center in Korea, such as Professor Kim Yeol, head of the Office of External Affairs and project director, Jeong Jaeyoung, head of the Urologic Cancer Center, and Kang Miju, chief planning officer. Participants also included the Vice Minister and directors from the Ministry of Health of Cote d'Ivoire and other officials; Adoubi Innocent, head of the National Cancer Control Program of Cote d'Ivoire, and related experts; officials from the Ministry of Health; experts in the field of health policy; and local medical staff participating in training programs to strengthen their capacity for early detection of prostate cancer.


Participants attended lectures by experts from the National Cancer Center on the current status of early detection of prostate cancer and the latest findings. In particular, the workshop focused on ways to introduce, in a manner suited to local conditions, tests such as the prostate-specific antigen (PSA) blood test, which can assess the risk of prostate cancer, and the digital rectal examination. They discussed improvement tasks in terms of policy formulation to expand early detection locally, improvement of socio-cultural awareness, securing medical infrastructure, training of professionals, and strengthening the competencies of healthcare workers.


Based on the discussions held at this workshop, a roadmap for the early detection of prostate cancer in Cote d'Ivoire is scheduled to be established at a second workshop in April this year. This is expected to serve as a starting point for improving early detection of prostate cancer and reducing mortality in Cote d'Ivoire, and the project aims to expand the successful experience of this initiative across the African continent.


Kim Yeol, head of the Office of External Affairs at the National Cancer Center, stated, "Prostate cancer is a cancer for which the incidence rate is high in advanced countries, but because diagnosis and treatment are well established, survival rates are very high. However, in developing countries such as those in Africa, it is a cancer that causes many deaths. This workshop is an important starting point in approaching early detection of prostate cancer not merely as a matter of medical technology, but from the perspective of strengthening national health systems," adding, "Through cooperation with Cote d'Ivoire, we will build a sustainable model for early detection of prostate cancer."



Jeong Jaeyoung, head of the Urologic Cancer Center, who also attended, emphasized, "The people of Cote d'Ivoire not only belong, racially, to a high-risk group for prostate cancer, but the malignancy of the cancer is also high, and in most cases patients are diagnosed at the metastatic stage and consequently die. To break this vicious cycle, policy support to increase the rate of early diagnosis must be implemented as a top priority, and I am confident that this will significantly reduce mortality from prostate cancer."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing